|
|
||||||||
12,14-Prostaglandin J2 Inhibits Glucocorticoid Binding and Signaling in Macrophages through a Peroxisome Proliferator-Activated Receptor
-Independent Process1
Institut National de la Santé et de la Recherche Médicale, Unité 489, Service dExplorations Fonctionnelles Multidisciplinaires, AP-HP Hôpital Tenon, Paris, France
15-Deoxy-
12,14-PGJ2 (15d-PGJ2) is involved in the control of inflammatory reaction. We tested the hypothesis that 15d-PGJ2 would exert this control in part by modulating the sensitivity of inflammatory cells to glucocorticoids. Human U937cells and mouse RAW 264.7 cells were exposed to 15d-PGJ2, and binding experiments were performed with [3H]dexamethasone as a glucocorticoid receptor (GR) ligand. 15d-PGJ2 caused a transient and concentration-dependent decrease in [3H]dexamethasone-specific binding to either cells through a decrease in the number of GR per cell without significant modification of the Kd value. These changes were related to functional alteration of the GR rather than to a decrease in GR protein. They did not require the engagement of peroxisome proliferator-activated receptor
(PPAR
), because the response to 15d-PGJ2 was neither mimicked by the PPAR
agonist ciglitazone nor prevented by the PPAR
antagonist bisphenol A diglycidyl ether. 15d-PGJ2 altered GR possibly through the interaction of its cyclopentenone ring with GR cysteine residues because the cyclopentenone ring per se could mimic the effect of 15d-PGJ2, and modification of GR cysteine residues with methyl methanethiosulfonate suppressed the response to 15d-PGJ2. Finally, 15d-PGJ2-induced decreases in glucocorticoid binding to GR resulted in parallel decreases in the ability of GR to activate the transcription of a glucocorticoid-inducible reporter gene and to reduce the expression of monocyte chemoattractant protein-1. Together these data suggest that 15d-PGJ2 limits glucocorticoid binding and signaling in monocytes/macrophages through a PPAR
-independent and cyclopentenone-dependent mechanism. It provides a way in which 15d-PGJ2 would exert proinflammatory activities in addition to its known anti-inflammatory activities.
This article has been cited by other articles:
![]() |
A. Ialenti, G. Grassia, P. Di Meglio, P. Maffia, M. Di Rosa, and A. Ianaro Mechanism of the Anti-Inflammatory Effect of Thiazolidinediones: Relationship with the Glucocorticoid Pathway Mol. Pharmacol., May 1, 2005; 67(5): 1620 - 1628. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |